SGLT2 inhibitors-induced electrolyte abnormalities: An analysis of the associated mechanisms. (Record no. 27483707)

MARC details
000 -LEADER
fixed length control field 01284 a2200349 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517171124.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201809s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1878-0334
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/j.dsx.2017.08.003
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Filippatos, T D
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20180912
245 00 - TITLE STATEMENT
Title SGLT2 inhibitors-induced electrolyte abnormalities: An analysis of the associated mechanisms.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Diabetes & metabolic syndrome
Date of publication, distribution, etc.
300 ## - PHYSICAL DESCRIPTION
Extent 59-63 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Review
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Benzhydryl Compounds
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Canagliflozin
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Diabetes Mellitus, Type 2
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Electrolytes
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Glucosides
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hypoglycemic Agents
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Metabolic Diseases
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Sodium-Glucose Transporter 2
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Sodium-Glucose Transporter 2 Inhibitors
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tsimihodimos, V
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Liamis, G
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Elisaf, M S
773 0# - HOST ITEM ENTRY
Title Diabetes & metabolic syndrome
Related parts vol. 12
-- no. 1
-- p. 59-63
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/j.dsx.2017.08.003">https://doi.org/10.1016/j.dsx.2017.08.003</a>
Public note Available from publisher's website

No items available.